Dr. Duncan

Clinic: Dr. Duncan received her MD/PhD from the University of Texas Southwestern Medical Center at Dallas. She completed a research track Internal Medicine residency and Allergy/Immunology fellowship here at the University of North Carolina at Chapel Hill and is board certified in Internal Medicine and Allergy/Immunology. She joined the faculty here at the University of North Carolina in 2009 and is part of the Thurston Arthritis Research Center. She sees patients with a wide variety of allergic or immunologic disorders. Dr. Duncan’s clinical interests are in treating patients with a variety of allergic disorders as well as immunologic disorders such as Common Variable Immunodeficiency (CVID).

Research: Dr. Duncan’s research interests focus on the study of the effects of cigarette smoke on the immune system to drive the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD). Dr. Duncan works with Dr. Claire Doerschuk and collaborators in the UNC Cystic Fibrosis and Pulmonary Diseases Research and Treatment Center to utilize mouse models to carry out these studies.

Education: Dr. Duncan supervises medical students, medicine residents, and Allergy/Immunology fellows in clinic and in the hospital. She has given local talks on various topics in Allergy/Immunology as well as her research interests. She also oversees undergraduate students in her laboratory, teaches medical students in small group immunology teaching sessions, and serves on graduate student qualifying exam committees.


Elizabeth Duncan, MD, PhD
Assistant Professor of Medicine

2012-2014 Appointed scholar in the UNC CTSA KL2 Program:
Interdisciplinary Clinical Research Career Development Program

2011 Selected to attend the CIS School in Primary Immunodeficiency Diseases

Grants and Collaborative Projects
UNC TCORS: The Impact of Tobacco Exposure on the Lung's Innate Defense System Project 3: Project 3: Mouse Models of Smoking-related Diseases: What is the Best Mimic of Human Disease?

NIH/NCRR (KL2 TR000084)
Studies of the pathogenesis of Chronic Obstructive Pulmonary Disease using a novel mouse model